In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species
- 1 February 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (2) , 465-467
- https://doi.org/10.1128/aac.41.2.465
Abstract
U-100592 and U-100766 are closely related antibiotics of the oxazolidinone class. Their in vitro activities were determined against 100 isolates of Staphylococcus aureus and 100 isolates of coagulase-negative Staphylococcus species by broth and agar dilution test methods. The MICs of both compounds by either test method at which 50 and 90% of isolates are inhibited were 2 and 4 micrograms/ml, respectively, for S. aureus and 1 to 2 micrograms/ml for coagulase-negative staphylococci. Time-kill assay with selected strains indicated a primarily bacteriostatic effect against staphylococci.Keywords
This publication has 8 references indexed in Scilit:
- In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsAntimicrobial Agents and Chemotherapy, 1996
- Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University WorkshopNew England Journal of Medicine, 1994
- The Crisis in Antibiotic ResistanceScience, 1992
- Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial EraScience, 1992
- Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesisAntimicrobial Agents and Chemotherapy, 1988
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988
- In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1988
- Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721Antimicrobial Agents and Chemotherapy, 1987